- Previous Close
0.3848 - Open
0.3476 - Bid 0.3186 x --
- Ask 0.3372 x --
- Day's Range
0.3476 - 0.3476 - 52 Week Range
0.3476 - 1.3190 - Volume
1,000 - Avg. Volume
17 - Market Cap (intraday)
8.085M - Beta (5Y Monthly) 3.90
- PE Ratio (TTM)
-- - EPS (TTM)
-2.2200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
www.cosmosholdingsinc.com123
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: V67A.F
View MorePerformance Overview: V67A.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: V67A.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: V67A.F
View MoreValuation Measures
Market Cap
7.47M
Enterprise Value
14.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.11
Price/Book (mrq)
0.26
Enterprise Value/Revenue
0.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-36.39%
Return on Assets (ttm)
-18.53%
Return on Equity (ttm)
-51.27%
Revenue (ttm)
56.04M
Net Income Avi to Common (ttm)
-33.81M
Diluted EPS (ttm)
-2.2200
Balance Sheet and Cash Flow
Total Cash (mrq)
3.34M
Total Debt/Equity (mrq)
31.52%
Levered Free Cash Flow (ttm)
-1.94M